These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24436514)

  • 1. Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.
    Zechlinski JJ; Rilling WS
    Semin Intervent Radiol; 2013 Mar; 30(1):21-7. PubMed ID: 24436514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous liver-directed therapies of intrahepatic cholangiocarcinoma.
    Morse B; McGettigan M; Kis B
    Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38900318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional Therapies of Cholangiocarcinoma.
    Sommer CM; Kauczor HU; Pereira PL
    Visc Med; 2016 Dec; 32(6):414-420. PubMed ID: 28229076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
    Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
    Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional Therapy for Intrahepatic Cholangiocarcinoma: The Role of Intra-Arterial Therapies.
    Gorji L; Aoun H; Critchfield J; Al Hallak N; Beal EW
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Intrahepatic Cholangiocarcinoma.
    Kodali S; Shetty A; Shekhar S; Victor DW; Ghobrial RM
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34072277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study.
    Liu G; Guo W; Wang H; Liu W; Lei L; Xie Q; Li X; Zou S; Wang P; Zhou H; Hu H
    Ann Palliat Med; 2021 Apr; 10(4):3673-3683. PubMed ID: 33691434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE.
    Currie BM; Soulen MC
    Semin Intervent Radiol; 2017 Jun; 34(2):92-100. PubMed ID: 28579676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma.
    Seidensticker R; Ricke J; Seidensticker M
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):319-32. PubMed ID: 25966431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis.
    Mosconi C; Solaini L; Vara G; Brandi N; Cappelli A; Modestino F; Cucchetti A; Golfieri R
    Cardiovasc Intervent Radiol; 2021 May; 44(5):728-738. PubMed ID: 33709272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic Cholangiocarcinoma.
    Padia SA
    Tech Vasc Interv Radiol; 2015 Dec; 18(4):227-35. PubMed ID: 26615163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic Cholangiocarcinoma.
    Entezari P; Riaz A
    Semin Intervent Radiol; 2020 Dec; 37(5):475-483. PubMed ID: 33328703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioembolization of Intrahepatic Cholangiocarcinoma: Patient Selection, Outcomes, and Competing Therapies.
    Ness JR; Molvar C
    Semin Intervent Radiol; 2021 Oct; 38(4):438-444. PubMed ID: 34629711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional therapy for cholangiocarcinoma.
    Kuhlmann JB; Blum HE
    Curr Opin Gastroenterol; 2013 May; 29(3):324-8. PubMed ID: 23337933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.
    Spolverato G; Kim Y; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Clark Gamblin T; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Tran TB; Wallis Marsh J; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):235-43. PubMed ID: 26059651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaanalysis of survival, complications, and imaging response following chemotherapy-based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma.
    Ray CE; Edwards A; Smith MT; Leong S; Kondo K; Gipson M; Rochon PJ; Gupta R; Messersmith W; Purcell T; Durham J
    J Vasc Interv Radiol; 2013 Aug; 24(8):1218-26. PubMed ID: 23725793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of surgical management of intrahepatic cholangiocarcinoma.
    Squires MH; Cloyd JM; Dillhoff M; Schmidt C; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):671-681. PubMed ID: 29911912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery.
    Kojima T; Umeda Y; Fuji T; Niguma T; Sato D; Endo Y; Sui K; Inagaki M; Oishi M; Ota T; Hioki K; Matsuda T; Aoki H; Hirai R; Kimura M; Yagi T; Fujiwara T
    PLoS One; 2020; 15(9):e0238392. PubMed ID: 32881910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram.
    Ge Y; Jeong S; Luo GJ; Ren YB; Zhang BH; Zhang YJ; Shen F; Cheng QB; Sui CJ; Wang HY; Xia Q; Chen L
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):138-146. PubMed ID: 32139295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.